Loading clinical trials...
Loading clinical trials...
A Phase 1 Single and Multiple Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Baxdrostat in Healthy Japanese and Caucasian Subjects
Conditions
Interventions
baxdrostat
Locations
1
United States
Anaheim Clinical Trials
Anaheim, California, United States
Start Date
July 5, 2022
Primary Completion Date
September 20, 2022
Completion Date
September 20, 2022
Last Updated
August 14, 2023
NCT06647511
NCT05746039
NCT07439939
NCT07218029
NCT06741436
NCT07098065
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions